MUC1 and breast carcinoma: For instance, it has been shown that recruiting the AS1411 and mucin-1 (MUC-1) as conventional targeting aptamers on the surface of MSNs can significantly increase selective delivery of DOX and strong toxicity against MCF-7 breast cancer cells [59, 60].